🇺🇸 Human albumin in United States

394 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 394

Most-reported reactions

1. Infusion Related Reaction — 52 reports (13.2%)
2. Anaemia — 49 reports (12.44%)
3. Diarrhoea — 49 reports (12.44%)
4. Dyspnoea — 43 reports (10.91%)
5. Pyrexia — 39 reports (9.9%)
6. Chills — 38 reports (9.64%)
7. Lymphocyte Count Decreased — 33 reports (8.38%)
8. Pneumonia — 33 reports (8.38%)
9. Drug Ineffective — 30 reports (7.61%)
10. Haemoglobin Decreased — 28 reports (7.11%)

Source database →

Frequently asked questions

Is Human albumin approved in United States?

Human albumin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Human albumin in United States?

Hamad Medical Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.